Dr Agarwals Eye Hospital Ltd vs Gujarat Kidney Super Speciality Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Dr Agarwals Eye Hospital Ltd is ₹ 5280 as of 30 Oct 15:30 . The P/E Ratio of Dr Agarwals Eye Hospital Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Gujarat Kidney & Super Speciality Ltd changed from 51.4 on March 2026 to 51.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Dr Agarwals Eye Hospital Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Gujarat Kidney & Super Speciality Ltd changed from ₹ 798.29 crore on March 2026 to ₹ 798.29 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 34.98 crore as compare to the Mar '26 revenue of ₹ 31.29 crore. This represent the growth of 11.79% The ebitda of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gujarat Kidney & Super Speciality Ltd for the Jun '26 is ₹ 9.07 crore as compare to the Mar '26 ebitda of ₹ 7.01 crore. This represent the growth of 29.39% The net profit of Dr Agarwals Eye Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Gujarat Kidney & Super Speciality Ltd changed from ₹ 2.96 crore to ₹ 5.32 crore over 8 quarters. This represents a CAGR of 34.06% The Dividend Payout of Dr Agarwals Eye Hospital Ltd changed from 5.85 % on March 2022 to 4.82 % on March 2026 . This represents a CAGR of -3.80% over 5 yearsThe Dividend Payout of Gujarat Kidney & Super Speciality Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Dr Agarwals Eye Hospital Ltd

Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994.
The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu.
Company has been a pioneer and leader into the Indian Ophthalmology market in the eye care division.
It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others.
It has presence in Tamil Nadu, Kerala and Rajasthan states. The Company is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre.
Subsequently, the Company name was changed to Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.
Further, Company' status was changed to a public limited company and the name of Company was changed to Gujarat Kidney and Super Speciality Limited' dated November 24, 2023 by the ROCs, Ahmedabad. The Company operate a chain of mid-sized multispecialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care.

FAQs for the comparison of Dr Agarwals Eye Hospital Ltd and Gujarat Kidney & Super Speciality Ltd

Which company has a larger market capitalization, Dr Agarwals Eye Hospital Ltd or Gujarat Kidney & Super Speciality Ltd?

Market cap of Dr Agarwals Eye Hospital Ltd is 2,551 Cr while Market cap of Gujarat Kidney & Super Speciality Ltd is 1,289 Cr

What are the key factors driving the stock performance of Dr Agarwals Eye Hospital Ltd and Gujarat Kidney & Super Speciality Ltd?

The stock performance of Dr Agarwals Eye Hospital Ltd and Gujarat Kidney & Super Speciality Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Agarwals Eye Hospital Ltd and Gujarat Kidney & Super Speciality Ltd?

As of October 31, 2026, the Dr Agarwals Eye Hospital Ltd stock price is INR ₹5280.15. On the other hand, Gujarat Kidney & Super Speciality Ltd stock price is INR ₹163.5.

How do dividend payouts of Dr Agarwals Eye Hospital Ltd and Gujarat Kidney & Super Speciality Ltd compare?

To compare the dividend payouts of Dr Agarwals Eye Hospital Ltd and Gujarat Kidney & Super Speciality Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.